{
    "2019-03-30": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop",
                "features": {
                    "keywords": [
                        "Alzheimer's",
                        "Disease",
                        "Drugs",
                        "Development",
                        "Biogen",
                        "Aducanumab",
                        "Flop"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}